Gene Therapy Target Identified for Parkinson's and Lewy Body Dementia

A mouse study suggests the APOE Christchurch mutation, previously linked to Alzheimer's protection, may also defend against Parkinson's and Lewy body dementia. Researchers observed that introducing this mutation prevented the buildup of toxic tau and alpha-synuclein proteins in mouse brains. This finding offers a potential gene therapy target for future treatments of these neurodegenerative disorders.